Category: Biomedical Innovation and Research

How Congress Will Weaken Innovative Medical Research

The future of innovative medical research under the Department of Defense is in jeopardy.  Due to four provisions (Sections 733, 891, 892, and 893) in the U.S. Senate version of the National Defense Authorization Act (NDAA) of 2018, medical research under the Department of Defense will become very limited.   Furthermore, programs like the Congressionally Directed ...